Business Model
Our Portfolio
Business Model
1. Co-Development
To jointly bring new drugs to market, we collaborate on co-development projects with industry partners. This business approach ensures effective product launches and sustained growth in global markets by enabling the sharing of resources, experience, and risk minimization.
2. Out-Licensing
For our developed products, we offer out-licensing opportunities so that partners can benefit from our cutting-edge formulations and technologies in various markets. For businesses looking to increase the range of therapeutic medicines they offer, our collection of authorized and pipeline pharmaceuticals offers a variety of out-licensing opportunities.